Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest
Abstract Nasopharyngeal carcinoma (NPC) is notably prevalent in East EROSYN FOR WOMEN and Southeast Asia, where despite advancements in radiotherapy leading to high control rates, challenges like radioresistance and collateral tissue damage remain significant.While Schisandrin B (SchB) has been demonstrated antitumor effects in various tumors, its